GlassScriptPhysician profile
Marshall G Solomon
NPI 1932147717
$8,564.18
in general payments reported to CMS, 2019-2025
40 companies · $1,673 in 2025
The $1,673 reported for 2025 was more than what 88% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $783 · 2020: $2,240 · 2021: $432 · 2022: $611 · 2023: $915 · 2024: $1,910 · 2025: $1,673.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,498.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,497.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle, INC | $2,048.88 | 2020 | |
| Kerecis Limited | $969.62 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Smith+Nephew, INC. | $789.83 | 2019-2025 | Grafix Pl, Pico, Pico 7 |
| Organogenesis INC. | $560.55 | 2021-2025 | Puraply Wound Matrix, Puraply, Apligraf |
| Abbvie INC. | $388.43 | 2022-2025 | |
| Averitas Pharma INC. | $348.58 | 2023-2025 | Qutenza |
| Stryker Corporation | $306.83 | 2019-2025 | Clottriever Bold Catheter |
| Depuy Synthes Sales INC. | $281.67 | 2020-2025 | Motoband, Foot Osteotomy Wedge System |
| Integra Lifesciences Corporation | $281.10 | 2022-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Treace Medical Concepts, INC. | $226.05 | 2024-2025 | |
| Aroa Biosurgery Incorporated | $212.66 | 2023 | |
| Misonix INC | $186.80 | 2019 | |
| Amgen INC. | $167.24 | 2024-2025 | Krystexxa |
| Penumbra, INC. | $141.61 | 2023 | Indigo System |
| Horizon Therapeutics Plc | $138.74 | 2019 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $135.37 | 2024 | Restrata Wound Matrix |
| Ani Pharmaceuticals, INC. | $125.00 | 2025 | Purified Cortrophin Gel |
| Bioventus LLC | $118.44 | 2021 | |
| Biocomposites INC | $111.03 | 2019-2023 | Stimulan |
| Tactile Systems Technology INC | $104.63 | 2022-2024 | Entre Plus, Flexitouch Plus |
| Acell, INC. | $101.43 | 2019 | |
| Medtronic, INC. | $94.44 | 2023 | Venaseal |
| Davol INC. | $89.48 | 2024 | Arista Ah Flexitip |
| Avita Medical Americas, LLC | $80.58 | 2024 | |
| Mimedx Group, INC. | $79.05 | 2024-2025 | |
| Convatec INC. | $73.61 | 2022 | |
| Paragon 28, INC. | $70.45 | 2020-2021 | |
| Hydrofera LLC | $57.57 | 2023 | Hydrofera Blue |
| Nevro Corp. | $34.28 | 2024 | Senza |
| Arthrosurface Incorporated | $32.72 | 2019-2020 | |
| Medical Device Business Services, INC. | $28.59 | 2021 | |
| Solventum Corporation | $25.78 | 2024 | V.A.C.Ulta, V.A.C. Veraflo |
| Amphastar Pharmaceuticals, INC. | $24.96 | 2025 | |
| Kci USA, INC. | $23.58 | 2021 | |
| Molnlycke Health Care US, LLC | $23.55 | 2025 | Exufiber, Mepilex Border Post-Op Ag, Exufiber Ag+ |
| Linvatec Corporation | $22.33 | 2021 | |
| Hartmann USA, INC. | $19.27 | 2025 | Zetuvit Plus 10x10 P10 |
| Highridge Medical LLC | $15.57 | 2024 | Ebi Osteogen Implantable Bone Growth Stimulator, Biomet Orthopak Non-Invasive Bone Growth Stimulator System, Biomet Ebi Bone Healing System |
| Ermi LLC | $14.95 | 2019 | |
| Medela LLC | $8.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marshall Solomon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.